The reason for this discrepancy is as follows: First, it should be noted that no more than 60 cases of RCC patients were included in either ABCG2(−), (+), and (++) subgroups in Wang’s study; thus, the different sample sizes perhaps are warranted for verification of the above conclusion. Here, ABCG2 is linked to renal cell carcinoma.